IR.BIOBLASTPHARMA.COM HOST
Our web crawlers caught that a single root page on ir.bioblastpharma.com took one thousand six hundred and seventy-two milliseconds to come up. We could not detect a SSL certificate, so in conclusion our crawlers consider this site not secure.
Internet Address
184.25.56.203
FAVORITE ICON
![](/f/ki3xjgvjtmkaeofdv4bingjj/256/ir.bioblastpharma.com.png)
TITLE
Investors Overview Bioblast PharmaDESCRIPTION
Thomas I. H. Dubin. Bioblast Pharma is a publicly traded, clinical-stage biotechnology company NASDAQ - ORPN committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Our therapeutic platforms are based on deep understanding of the disease-causing biological processes, and can potentially offer solutions for several diseases that share the same biological pathology. SCA3 POC - 2015 International Ataxia Research Conference. November 29, 2016. Biobl.CONTENT
This web site has the following in the web page, "Bioblast Pharma is a publicly traded, clinical-stage biotechnology company NASDAQ - ORPN committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases." Our analyzers noticed that the web page also stated " Our therapeutic platforms are based on deep understanding of the disease-causing biological processes, and can potentially offer solutions for several diseases that share the same biological pathology." The Website also said " SCA3 POC - 2015 International Ataxia Research Conference."